Lymphoma is a blood cancer that develops when lymphocytes, part of your immune system, grow out of control. The problem with lymphoma is that cancer cells use the immune response to give them an extra advantage to go undetected and continue to replicate. The successful immune evasion by cancer cells means that the body is … Continued
Dr Charles De Bock is the very worthy recipient of the HSANZ/ Snowdome Foundation Mid-Career Award for outstanding research into T-cell acute lymphocytic leukaemia (ALL). Charles is incredibly animated and excited when he begins to talk about finding better treatments for childhood leukaemia through research and his enthusiasm is infectious. The award-winning research conducted by … Continued
Maddie Riewoldt’s Vision, the Snowdome Foundation and the Gunn Family are thrilled to announce Dr Katherine Cummins as the second ever recipient of the Gunn Family Women in Haematology Fellowship. This fellowship endorses the passion of both organisations to support the advancement of women in medical research and importantly offers long-term commitment to funding, combined … Continued
West Australian family the Zuks were introduced to cancer in 2013. Cancer had never been a part of their lives. They were all fit and healthy, or so they thought. But at the age of 60, Rita, mother to Lincoln, Renee and Clayton, wife to Len, and the heart of the family, detected a lump. … Continued
The Leukemia & Lymphoma Society conducted a large trial to examine if the mRNA (Pfizer and Moderna) COVID-19 vaccines provided antibody protection against the SARS-CoV-2 virus in people with a blood cancer. It was just published in Cancer Cell. Two weeks after their second COVID-19 vaccine 1400 blood cancer patients had their antibody levels tested … Continued
Dr Mary Ann Anderson was awarded the Gandel Philanthropy – Snowdome Foundation Innovation Fellowship in 2016. Since that time, she has become recognised as a world-leading expert through her pioneering work uncovering invaluable information about the novel treatment, venetoclax in the treatment of lymphoma and chronic lymphocytic leukaemia. Funded by Gandel Philanthropy, through the Snowdome … Continued
Dr Belinda Guo is the recipient of the 2019-2021 Gunn Family National Career Development Fellowship for Women in Haematology. For the past three years Belinda has researched novel blood biomarkers for predicting bone marrow failure in myeloproliferative neoplasms. During that time she has made great advances in identifying markers to monitor disease progression. Myeloproliferative neoplasm … Continued
Forty per cent of patients with the most common form of aggressive non-Hodgkin lymphoma (diffuse large B-cell lymphoma) either relapse or are refractory to first line treatment with rituximab and chemotherapy. Stem-cell transplant was the only available treatment option thought to reliably induce cures until the approval of chimeric antigen receptor (CAR) T-cell therapy. However, … Continued
For anyone living with a blood cancer, chimeric antigen receptor T-cell therapy (CAR-T) is a lifeline. Leukaemia and lymphoma patients who have exhausted all other treatment options are given another chance at life. Their own immune system T-cells are genetically engineered to recognise cancer cells and destroy them. It is expected that the demand for … Continued